Related references
Note: Only part of the references are listed.FACS analysis of Stat3/5 signaling reveals sensitivity to G-CSF and IL-6 as a significant prognostic factor in pediatric AML: a Children's Oncology Group report
Michele S. Redell et al.
BLOOD (2013)
Cytoprotection by the modulation of mitochondrial electron transport chain: The emerging role of mitochondrial STAT3
Karol Szczepanek et al.
MITOCHONDRION (2012)
Regulating the regulator: post-translational modification of RAS
Ian M. Ahearn et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Mitochondrial-targeted Signal Transducer and Activator of Transcription 3 (STAT3) Protects against Ischemia-induced Changes in the Electron Transport Chain and the Generation of Reactive Oxygen Species
Karol Szczepanek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
PTEN loss in the continuum of common cancers, rare syndromes and mouse models
M. Christine Hollander et al.
NATURE REVIEWS CANCER (2011)
Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion
Kerstin Boengler et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis
Julia Bollrath et al.
CANCER CELL (2009)
IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
Sergei Grivennikov et al.
CANCER CELL (2009)
Mitochondrial STAT3 Supports Ras-Dependent Oncogenic Transformation
Daniel J. Gough et al.
SCIENCE (2009)
Function of Mitochondrial Stat3 in Cellular Respiration
Joanna Wegrzyn et al.
SCIENCE (2009)
The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation
Ralph J. DeBerardinis et al.
CELL METABOLISM (2008)
Recent progress in targeting the Raf/MEK/ERK pathway with inhibitors in cancer drug discovery
N Thompson et al.
CURRENT OPINION IN PHARMACOLOGY (2005)
Signaling interplay in Ras superfamily function
N Mitin et al.
CURRENT BIOLOGY (2005)
RaIGDS is required for tumor formation in a model of skin carcinoigenesis
A González-García et al.
CANCER CELL (2005)
STAT proteins:: From normal control of cellular events to tumorigenesis
V Calò et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2003)
The genetics of malignant melanoma: Lessons from mouse and man
L Chin
NATURE REVIEWS CANCER (2003)
Targeting ras signalling pathways in cancer therapy
J Downward
NATURE REVIEWS CANCER (2003)
Distinct requirements for Ras oncogenesis in human versus mouse cells
NM Hamad et al.
GENES & DEVELOPMENT (2002)
Roles of STAT3 defined by tissue-specific gene targeting
S Akira
ONCOGENE (2000)
Serine phosphorylation of STATs
T Decker et al.
ONCOGENE (2000)
Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR
K Yokogami et al.
CURRENT BIOLOGY (2000)
Share Paper
